Medical Research
(H900)
IRS Verified
DX Registered
990 on File
TRUDEAU INSTITUTE INC
Financial strength (30%)
92/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
Register and add impact metrics to be rated above three stars
CharityAI™ Score
Not yet evaluated
Mission Statement
Carrying forward the mission of Dr. E.L. Trudeau’s Saranac Laboratory established in 1884, Trudeau Institute is now an independent biomedical research organization dedicated to the study of immune responses to diseases including tuberculosis, influenza, coronavirus, antibiotic-resistant pathogens, and other emerging pathogens The Institute also advances the development of vaccines, therapeutics, and strategies to mitigate risks to human health.
Financial Overview — FY 2024
$8.2M
Total Revenue
$10.3M
Total Expenses
$18.8M
Net Assets
89
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
88.0%
Fundraising Efficiency
N/A
Operating Reserve
21.84x
Liability-to-Asset
4.6%
Revenue Diversification
77.3%
Executive Compensation
$376K
Compared with Peers
FY 2024
Compared with 98 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
88.0% | 82.0% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
10.4% | 12.7% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
1.6% | 0.7% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
21.8 mo | 14.5 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
4.6% | 21.3% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
77.3% | 90.8% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
15.5% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
1.9% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-25.4% | -1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $8.2M | $10.3M | $18.8M | 88.0% | 89 |
| 2023 | $7.1M | $10.1M | $20.8M | 84.8% | 82 |
| 2022 | $6.0M | $11.1M | $24.3M | 83.7% | 92 |
| 2021 | $8.4M | $10.2M | N/A | — | 87 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.